US: 800.298.5699
Int'l: +1.240.747.3093
Matching geography
Reports matching your search in:
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!

Personalized Medicine Market Research Reports & Industry Analysis

RSS Feeds

Personalized Medicine Industry Research & Market Reports

Next Generation Sequencing
9/9/2013 | published by: Yole Developpement
... sequence DNA at unprecedented speed, enabling previously unimaginable novel healthcare applications. By providing valuable data on patient genomes, NGS technologies are filling the gap separating traditional and personalized medicine. Along with a global shift toward ...  |  read more...
USD 8,200
Cancer Peptides: From First-in-Class to Best-in-Class?
1/7/2013 | published by: BioSeeker Group AB
... Which targets, tumor types and companies are setting the path? What is first-in-class in the cancer peptide pipeline? Is First-in-Class the Best-in-Class? Indication expansion opportunities Drug repositioning opportunities Which pathways are targeted, by what and ...  |  read more...
USD 3,675
MEDTECH : Microfluidic Applications In The Pharmaceutical, Life Sciences, In Vitro Diagnostic And Medical Device Markets
6/24/2013 | published by: Yole Developpement
... device market. The microfluidic device market is expected to reach $5.7B by 2018! The microfluidic device market will grow swiftly, from $1.4B in 2013 to $5.7B by 2018. This impressive 27% growth will be fueled ...  |  read more...
USD 7,990
Personalized Medicine and Companion Diagnostic Market Q2 2013- A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
7/23/2013 | published by: Kelly Scientific Publications
... impact on the health system. This report tackles the growing market interest in pharmacogenomics, companion diagnostics and the associated market environment. Individualized, targeted or personalized medicine aims to increase the efficacy of therapeutics via genetic ...  |  read more...
USD 3,660
US Personalized Cancer Genome Sequencing Marketrncos
5/1/2013 | published by: RNCOS
... the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment. In order to properly analyze the virtues and significance of the US personalized cancer Whole-Genome ...  |  read more...
USD 1,200
Personalized Medicine Market Analysis
5/1/2013 | published by: RNCOS
... per individuals. The growing research applications and identification of molecular markers towards disease predisposition and progression have led to the growth of personalized medicine. Industry players have also rapidly adopted this field and are progressing ...  |  read more...
USD 1,200
The 2013-2018 Outlook for Genetic Testing Services in Greater China
5/19/2013 | published by: Icon Group International, Inc.
... Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or ...  |  read more...
USD 495
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) Market & Forecast
6/13/2013 | published by: Renub Research
... as well and slowly becoming the reality of future in the diagnostics industry By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 ...  |  read more...
USD 1,400
Predictive Diagnostics
9/1/2013 | published by: Global Industry Analysts
... are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 58 companies including many key and niche players such as Abbott Molecular, Almac Group ...  |  read more...
USD 4,500
Breast Cancer Therapies Markets
11/1/2012 | published by: TriMark Publications
... such barriers to entry as a stringent regulatory environment and the incursion of cost containment within oncology. Breast Cancer Therapies Markets provides comprehensive information on major and minor shapers of the breast cancer drug treatment ...  |  read more...
USD 3,400
Genetic Testing Market Outlook to 2017
5/1/2013 | published by: RNCOS
... 140-page report. On account of our analysis of the past and present market trends; drivers; and existing strengths and challenges; forecast for genetic testing has been drawn, according to which, the market is likely to ...  |  read more...
USD 1,200
Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players)
4/1/2009 | published by: Kalorama Information
... personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this ...  |  read more...
USD 995
SNP Genotyping and Analysis Markets and the Future of SNPs in Personalized Medicine
2/1/2010 | published by: Kalorama Information
... exhibited by a living organism. For this reason, SNP analysis represents one of many possible pathways to personalzied medicine. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and ...  |  read more...
USD 1,995
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
... the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara ...  |  read more...
USD 3,500
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine)
6/1/2008 | published by: Kalorama Information
... the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as ...  |  read more...
USD 2,995
The Opportunity for the Obama Economic Stimulus Bill to Accelerate Personalized Medicine
3/2/2009 | published by: IDC
... accelerate the broad adoption of personalized medicine (PM) in the United States. From the broad creation of electronic medical records (EMRs) to comparative effectiveness research to expanded National Institutes of Health (NIH) research, the economic ...  |  read more...
USD 1,500
Personalized Medicine: Technologies and the Global Market
7/1/2009 | published by: BCC Research
... for the worldwide market for personalized medicine Estimates the growth of all submarkets for personalized medicine in terms of technology, products, services, geography and applications areas Analyzes the current personalized medicine business model and looks ...  |  read more...
USD 6,650
Combination Drug/Diagnostic Products and Other Applications of Personalized Medicine-Strategic Issues Facing Companies in this Market
4/1/2010 | published by: CHI Insight Pharma Reports
... Personalized medicine has emerged as an important field for companies in both the pharmaceutical and the diagnostic industries. While many drugs in development and on the market today still follow the traditional approach where drugs ...  |  read more...
USD 2,995
Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
12/1/2010 | published by: GBI Research
... and Proteomics to Challenge Traditional Therapeutics” that provides key data, information and analysis of the major trends and issues in Personalized Medicine Market. The report provides a comprehensive insight into the role of Human Genomics ...  |  read more...
USD 3,500
Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine
1/1/2011 | published by: JZMed, Inc.
... Their efforts are leading to the gradual realization of personalized medicines. On the surface, what drive the gradual realization of personalized medicines are the technologies developed in molecular biomarker and diagnostics. However, it’s the genomics ...  |  read more...
USD 3,285
Personalized Medicine Market Worldwide (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast
2/14/2010 | published by: Renub Research
... from past trends to future scenario (2006 to 2015). Personalized medicine segments like Genetically Modified (GM) Products, Wellness & Disease Management, Targeted Biologics, Other Molecular Diagnostics, Genomics and Proteomics and Consumer Self Diagnostic markets data ...  |  read more...
USD 1,100
Personalized Medicine - Opening Doors and Overcoming Challenges
11/1/2010 | published by: CBR Pharma Insights, LLC
... has begun to change as more personalized medicines have been developed outside of the oncology field. The spread of personalized medicine to other fields has increased the challenge of physician uptake, with many GPs not ...  |  read more...
USD 3,900
Conference Documentation: Personalised Medicine
10/12/2010 | published by: SMI Publishing, Ltd
... latest in science, R&D, business strategies and legal issues for developing personalised therapeutics, and successfully introducing them to the marketplace. Covering various approaches towards developing personalised therapeutics - biomarkers, pharmacogenomics, pharmacogenetics and stem cells, the ...  |  read more...
USD 800
Business Strategy: Personalized Medicine Looking Forward
12/13/2009 | published by: IDC
... key signposts of progress, market drivers impacting the segment, and both near- and long-term market opportunities for the segment. As we continue to hear more and more about broad efforts to transform the health industry ...  |  read more...
USD 4,500
Combination Drug Diagnostics: Fueling Growth of Personalized Medicine Report
4/1/2010 | published by: CHI Insight Pharma Reports
... combinations Emerging new applications Strategic options for pharmaceutical and diagnostic companies Regulatory and reimbursement issues Physician education and acceptable hurdles Interviews with experts Combination Drug/Diagnostics: Fueling Growth of Personalized Medicine examines the role of Rx/Dx ...  |  read more...
USD 3,750